欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0117/001
药品名称Dexamethasone Alapis 2mg/5ml Oral solution
活性成分
    • dexamethasone sodium phosphate 0.4 mg/ml
剂型Oral solution
上市许可持有人Alapis S.A., 2, Aftokratoros Nikolaou Street, 17671 Athens Greece.
参考成员国 - 产品名称Malta (MT)
Dexamethasone Alapis 2mg/5ml Oral Solution
互认成员国 - 产品名称
    • Germany (DE)
      Dexamethasone Alapis 2 mg/5 ml Lösung zum Einnehmen
    • Belgium (BE)
    • United Kingdom (Northern Ireland) (XI)
    • Portugal (PT)
    • Greece (GR)
    • Bulgaria (BG)
      Dexamethasone Alapis
    • Cyprus (CY)
      DEXAMETHASONE ALAPIS 2mg/5ml ORAL SOLUTION
    • Romania (RO)
      Dexametazona Alapis 2 mg/5 ml solutie orala
许可日期2011/11/21
最近更新日期2017/07/28
药物ATC编码
    • H02AB02 dexamethasone
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase